Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Remicade

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Remicade was produced by Johnson & Johnson, Mitsubishi Tanabe Pharma and Merck & Co..

J&J's Caruso bullish on Remicade defence plans

J&J's Caruso bullish on Remicade defence plans segment. Inflectra will launch at a 15% discount to Remicade, but average selling price of J&J's drug is already "significantly lower than the list price," he said. ... In other markets such as Canada, Australia and Brazil where biosimilar versions of

Biologics set to revolutionise the gastrointestinal market

Biologics set to revolutionise the gastrointestinal market Remicade (infliximab), begin to lose their patent protection.

Biogen launches Remicade biosimilar in the UK

Biogen launches Remicade biosimilar in the UK Flixabi joins Pfizer's Inflectra and Mundipharma's Remsima, two Remicade biosimilars manufactured by Celltrion, in looking to take sales from Remicade. ... In doing so it matched Remicade's approval for the treatment of Crohn's disease, ulcerative colitis

Novartis claims first place for its biosimilar Enbrel in US

Novartis claims first place for its biosimilar Enbrel in US The US biosimilar market is still in its infancy with just two products approved to date, namely Zarxio and Pfizer's Inflectra, a version of Johnson &Johnson's TNF inhibitor Remicade ... In some cases - for example in Norway where Remsima is priced at a

J&J is to appeal Remicade patent ruling in US

J&J is to appeal Remicade patent ruling in US In Europe - where Remicade is marketed by MSD - the product has been facing direct competition since biosimilar versions were launched in 2014/2015. ... J&J's other patent protection for Remicade in the US expires on 3 October.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics